COMPANY PROFILE // THE 014 REPORT
Lakefront Biotherapeutics NV
LKFT (Nasdaq) · GLPGF (OTC) · Formerly: GALAPAGOS NV
Assembled from 2 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
Lakefront Biotherapeutics NV is an SEC-registered company in pharmaceutical preparations, based in 2800 Mechelen; listed as LKFT (Nasdaq), GLPGF (OTC).[source] It has filed 59 documents with the SEC in the last 12 months; the latest is Form 6-K, filed 2026-11-18.[source] Its largest institutional holders on 13F filings are GILEAD SCIENCES, INC., TANG CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- GILEAD SCIENCES, INC.$500.2M
- TANG CAPITAL MANAGEMENT LLC$113.5M
- Madison Avenue Partners, LP$103.4M
- Prosight Management, LP$61.3M
- EcoR1 Capital, LLC$50.0M
- AMERIPRISE FINANCIAL INC$38.1M
- DME Capital Management, LP$14.5M
- RENAISSANCE TECHNOLOGIES LLC$12.2M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. (Wikipedia, CC BY-SA 4.0)
Links
- Official website (Wikidata or the SEC record)
- Wikipedia
- Wikidata
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001421876 | source |
| EIN | 00-0000000 | source |
| NY DOS IDpossible match | 2008014 | record |
| Business address (SEC) | SCHALIENHOEVEDREEF 20T, 2800 MECHELEN | source |
Does not exist in the records we hold: LEI, UEI, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
No dated renewal or filing deadline is held for this entity: no SAM registration, no LEI and no periodic filing schedule on record.
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-18 filing 6-K · SEC EDGAR
- 2026-11-16 filing 6-K · SEC EDGAR
- 2026-11-12 filing 6-K · SEC EDGAR
- 2026-11-12 filing 6-K · SEC EDGAR
- 2026-11-04 filing 6-K · SEC EDGAR
- 2026-11-02 filing 6-K · SEC EDGAR
- 2026-10-20 filing 6-K · SEC EDGAR
- 2026-10-15 filing 6-K · SEC EDGAR
- 2026-10-13 filing 6-K · SEC EDGAR
- 2026-10-09 filing 6-K · SEC EDGAR
- 2026-10-06 filing 6-K · SEC EDGAR
- 2026-09-29 filing 6-K · SEC EDGAR
- 2026-09-23 filing 6-K · SEC EDGAR
- 2026-09-15 filing 6-K · SEC EDGAR
- 2026-09-08 filing 6-K · SEC EDGAR
- 2026-09-08 filing 6-K · SEC EDGAR
- 2026-09-01 filing 6-K · SEC EDGAR
- 2026-08-25 filing 6-K · SEC EDGAR
- 2026-08-25 filing 6-K · SEC EDGAR
- 2026-08-25 filing 6-K · SEC EDGAR
- 2026-08-18 filing 6-K · SEC EDGAR
- 2026-08-12 filing 6-K · SEC EDGAR
- 2026-08-12 filing 6-K · SEC EDGAR
- 2026-08-04 filing 6-K · SEC EDGAR
- 2026-07-28 filing 6-K · SEC EDGAR
- 2026-07-21 filing 6-K · SEC EDGAR
- 2026-07-15 filing 6-K · SEC EDGAR
- 2026-07-13 filing 6-K · SEC EDGAR
- 2026-07-07 filing 6-K · SEC EDGAR
- 2026-06-30 filing 6-K · SEC EDGAR
170 earlier entries
- 2026-06-30 filing 6-K
- 2026-06-24 filing 6-K
- 2026-06-16 filing 6-K
- 2026-06-09 filing 6-K
- 2026-06-09 filing 6-K
- 2026-06-05 filing 6-K
- 2026-05-27 filing 6-K
- 2026-05-08 filing 424B3
- 2026-05-06 filing 6-K
- 2026-05-06 name change Name changed from GALAPAGOS NV
- 2026-04-29 filing 6-K
- 2026-03-31 filing 6-K
- 2026-03-30 filing 6-K
- 2026-03-26 filing Annual report (20-F)
- 2026-03-24 filing 6-K
- 2026-03-17 filing 6-K
- 2026-03-10 filing 6-K
- 2026-03-06 filing 6-K
- 2026-03-05 filing 6-K
- 2026-03-04 filing 6-K
- 2026-02-23 filing 6-K
- 2026-02-19 filing 6-K
- 2026-02-17 filing 6-K
- 2026-02-10 filing 6-K
- 2026-01-05 filing 6-K
- 2025-12-18 filing 6-K
- 2025-12-10 filing S-8
- 2025-12-08 filing 6-K
- 2025-11-26 filing 6-K
- 2025-11-06 filing 6-K
- 2025-11-03 filing 6-K
- 2025-10-30 filing 6-K
- 2025-10-24 filing 6-K
- 2025-10-21 filing 6-K
- 2025-10-16 filing 6-K
- 2025-10-01 filing 6-K
- 2025-08-07 filing 6-K
- 2025-08-06 filing 6-K
- 2025-07-28 filing SCHEDULE 13D/A
- 2025-07-24 filing 6-K
- 2025-07-24 filing 6-K
- 2025-07-23 filing 6-K
- 2025-06-25 filing 6-K
- 2025-06-20 filing 6-K
- 2025-06-13 filing 6-K
- 2025-05-28 filing 6-K
- 2025-05-19 filing SCHEDULE 13D/A
- 2025-05-14 filing 6-K
- 2025-05-13 filing 6-K
- 2025-04-29 filing 6-K
- 2025-04-23 filing 6-K
- 2025-04-21 filing 6-K
- 2025-04-15 filing 6-K
- 2025-03-28 filing 6-K
- 2025-03-27 filing Annual report (20-F)
- 2025-02-24 filing 6-K
- 2025-02-18 filing 6-K
- 2025-02-14 filing SCHEDULE 13D
- 2025-02-12 filing 6-K
- 2025-01-10 filing SCHEDULE 13D/A
- 2025-01-08 filing 6-K
- 2025-01-08 filing 6-K
- 2024-12-09 filing 6-K
- 2024-11-20 filing S-8
- 2024-11-06 filing 6-K
- 2024-10-31 filing 6-K
- 2024-10-08 filing SC 13D/A
- 2024-10-07 filing 6-K
- 2024-09-30 filing 6-K
- 2024-09-16 filing 6-K
- 2024-09-03 filing 6-K
- 2024-08-23 filing 6-K
- 2024-08-23 filing SC 13D
- 2024-08-21 filing 6-K
- 2024-08-02 filing 6-K
- 2024-06-17 filing 6-K
- 2024-05-30 filing 6-K
- 2024-05-16 filing 6-K
- 2024-05-16 filing 6-K
- 2024-05-03 filing 6-K
- 2024-05-02 filing SC 13D/A
- 2024-05-01 filing 6-K
- 2024-05-01 filing 6-K
- 2024-04-08 filing 6-K
- 2024-03-29 filing 6-K
- 2024-03-29 filing 6-K
- 2024-03-28 filing Annual report (20-F)
- 2024-02-23 filing 6-K
- 2024-02-16 filing 6-K
- 2024-02-06 filing 6-K
- 2024-01-05 filing 6-K
- 2024-01-04 filing 6-K
- 2024-01-04 filing 6-K
- 2023-12-21 filing 6-K
- 2023-12-12 filing 6-K
- 2023-12-12 filing 6-K
- 2023-12-04 filing S-8
- 2023-11-03 filing 6-K
- 2023-11-02 filing 6-K
- 2023-09-20 filing 6-K
- 2023-08-30 filing 6-K
- 2023-08-04 filing 6-K
- 2023-06-15 filing 6-K
- 2023-06-13 filing 6-K
- 2023-06-12 filing 6-K
- 2023-05-26 filing 6-K
- 2023-05-23 filing 6-K
- 2023-05-09 filing 6-K
- 2023-05-05 filing 6-K
- 2023-05-02 filing 6-K
- 2023-05-02 filing 6-K
- 2023-04-26 filing 6-K
- 2023-04-25 filing 6-K
- 2023-03-31 filing 6-K
- 2023-03-27 filing 6-K
- 2023-03-23 filing Annual report (20-F)
- 2023-03-23 filing 6-K
- 2023-02-28 filing 6-K
- 2023-02-24 filing 6-K
- 2023-02-10 filing 6-K
- 2023-02-08 filing 6-K
- 2023-01-19 filing 6-K
- 2023-01-10 filing 6-K
- 2023-01-05 filing 6-K
- 2023-01-05 filing 6-K
- 2022-12-23 filing 6-K
- 2022-12-13 filing 6-K
- 2022-12-12 filing S-8
- 2022-11-14 filing 6-K
- 2022-11-09 filing 6-K
- 2022-11-07 filing 6-K
- 2022-11-04 filing 6-K
- 2022-10-17 filing 6-K
- 2022-10-06 filing 6-K
- 2022-10-04 filing 6-K
- 2022-09-27 filing 6-K
- 2022-08-30 filing 6-K
- 2022-08-24 filing 6-K
- 2022-08-19 filing 6-K
- 2022-08-09 filing 6-K
- 2022-08-08 filing 6-K
- 2022-06-23 filing 6-K
- 2022-06-23 filing 6-K
- 2022-06-02 filing 6-K
- 2022-05-31 filing 6-K
- 2022-05-11 filing 6-K
- 2022-05-09 filing 6-K
- 2022-05-06 filing 6-K
- 2022-04-28 filing 6-K
- 2022-04-27 filing 6-K
- 2022-04-11 filing 6-K
- 2022-03-28 filing 6-K
- 2022-03-25 filing 6-K
- 2022-03-24 filing Annual report (20-F)
- 2022-03-24 filing 6-K
- 2022-02-24 filing 6-K
- 2022-02-07 filing 6-K
- 2022-02-07 filing 6-K
- 2022-01-27 filing 6-K
- 2022-01-26 filing 6-K
- 2022-01-19 filing 6-K
- 2022-01-13 filing 6-K
- 2022-01-10 filing 6-K
- 2021-12-06 filing 6-K
- 2021-11-29 filing 6-K
- 2021-11-17 filing 6-K
- 2021-11-08 filing 6-K
- 2021-11-02 filing SC 13D
- 2021-10-26 filing S-8
- 2021-10-06 filing 6-K
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-18 (within 7 days) 6-K filed (FORM 6-K)
- 2026-11-16 (within 7 days) 6-K filed (FORM 6-K)
- 2026-11-12 (within 30 days) 6-K filed (FORM 6-K)
- 2026-11-12 (within 30 days) 6-K filed (FORM 6-K)
- 2026-11-04 (within 30 days) 6-K filed (FORM 6-K)
- 2026-11-02 (within 30 days) 6-K filed (FORM 6-K)
- 2026-10-20 (older) 6-K filed (FORM 6-K)
- 2026-10-15 (older) 6-K filed (FORM 6-K)
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:LKFT The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
2 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1421876 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | LKFT / Nasdaq, OTC | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | 36315X101 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001421876 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | other | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-22 03:05 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-22 03:05 UTC | Report an error |
| State of incorporation | C9 | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-22 03:05 UTC | Report an error |
| Business address | SCHALIENHOEVEDREEF 20T, 2800 MECHELEN | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-22 03:05 UTC | Report an error |
| Exchanges | Nasdaq, OTC | 2026-11-18 | SEC EDGAR company profile | as filed | 2026-11-22 03:05 UTC | Report an error |
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-18 Filing 6-K filed (FORM 6-K)
- 2026-11-16 Filing 6-K filed (FORM 6-K)
- 2026-11-12 Filing 6-K filed (FORM 6-K)
- 2026-11-12 Filing 6-K filed (FORM 6-K)
- 2026-11-04 Filing 6-K filed (FORM 6-K)
- 2026-11-02 Filing 6-K filed (FORM 6-K)
- 2026-10-20 Filing 6-K filed (FORM 6-K)
- 2026-10-15 Filing 6-K filed (FORM 6-K)
- 2026-10-13 Filing 6-K filed (FORM 6-K)
- 2026-10-09 Filing 6-K filed (FORM 6-K)
- 2026-10-06 Filing 6-K filed (FORM 6-K)
- 2026-09-29 Filing 6-K filed (FORM 6-K)
- 2026-09-23 Filing 6-K filed (FORM 6-K)
- 2026-09-15 Filing 6-K filed (FORM 6-K)
- 2026-09-08 Filing 6-K filed (FORM 6-K)
- 2026-09-08 Filing 6-K filed (FORM 6-K)
- 2026-09-01 Filing 6-K filed (FORM 6-K)
- 2026-08-25 Filing 6-K filed (FORM 6-K)
- 2026-08-25 Filing 6-K filed (FORM 6-K)
- 2026-08-25 Filing 6-K filed (FORM 6-K)
- 2026-08-18 Filing 6-K filed (FORM 6-K)
- 2026-08-12 Filing 6-K filed (FORM 6-K)
- 2026-08-12 Filing 6-K filed (FORM 6-K)
- 2026-08-04 Filing 6-K filed (FORM 6-K)
- 2026-07-28 Filing 6-K filed (FORM 6-K)
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES, INC. | $500,157,715 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 2 | TANG CAPITAL MANAGEMENT LLC | $113,504,010 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 3 | Madison Avenue Partners, LP | $103,365,254 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 4 | Prosight Management, LP | $61,259,453 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 5 | EcoR1 Capital, LLC | $49,980,228 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 6 | AMERIPRISE FINANCIAL INC | $38,140,727 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 7 | DME Capital Management, LP | $14,472,725 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 8 | RENAISSANCE TECHNOLOGIES LLC | $12,225,844 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 9 | BlackRock, Inc. | $10,137,797 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
| 10 | Point72 Asset Management, L.P. | $8,089,024 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:05 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
2 state and city records carry this company's exact name, from 2 sources. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchLakefront Biotherapeutics NV · exact legal name · sx:ctgov:h49a35fa5c0055095 Compare
New York corporations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchGALAPAGOS, INC. · name equals 'Galapagos' but other unrelated entities share it · sx:nydos:2008014 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1421876.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001421876. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.